274 related articles for article (PubMed ID: 28666474)
21. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
Schilder L; Nurmohamed SA; Bosch FH; Purmer IM; den Boer SS; Kleppe CG; Vervloet MG; Beishuizen A; Girbes AR; Ter Wee PM; Groeneveld AB;
Crit Care; 2014 Aug; 18(4):472. PubMed ID: 25128022
[TBL] [Abstract][Full Text] [Related]
22. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.
du Cheyron D; Bouchet B; Bruel C; Daubin C; Ramakers M; Charbonneau P
Crit Care; 2006; 10(2):R45. PubMed ID: 16542495
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the heparin-binding AN69 ST hemodialysis membrane: II. Clinical studies without heparin administration.
Lavaud S; Paris B; Maheut H; Randoux C; Renaux JL; Rieu P; Chanard J
ASAIO J; 2005; 51(4):348-51. PubMed ID: 16156297
[TBL] [Abstract][Full Text] [Related]
24. Prefilter bivalirudin for preventing hemofilter occlusion in continuous renal replacement therapy.
Mueller SW; MacLaren R; Fish DN; Kiser TH
Ann Pharmacother; 2009 Jul; 43(7):1360-5. PubMed ID: 19584380
[TBL] [Abstract][Full Text] [Related]
25. The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial.
Schefold JC; von Haehling S; Pschowski R; Bender T; Berkmann C; Briegel S; Hasper D; Jörres A
Crit Care; 2014 Jan; 18(1):R11. PubMed ID: 24405734
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.
Stucker F; Ponte B; Tataw J; Martin PY; Wozniak H; Pugin J; Saudan P
Crit Care; 2015 Mar; 19(1):91. PubMed ID: 25881975
[TBL] [Abstract][Full Text] [Related]
27. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
[TBL] [Abstract][Full Text] [Related]
28. Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.
Palsson R; Laliberte KA; Niles JL
Clin Nephrol; 2006 Jan; 65(1):34-42. PubMed ID: 16429840
[TBL] [Abstract][Full Text] [Related]
29. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients.
Tan HK; Baldwin I; Bellomo R
Intensive Care Med; 2000 Nov; 26(11):1652-7. PubMed ID: 11193272
[TBL] [Abstract][Full Text] [Related]
30. In vitro Evaluation of Linezolid and Doripenem Clearance with Different Hemofilters.
Hiraiwa T; Moriyama K; Matsumoto K; Shimomura Y; Kato Y; Yamashita C; Hara Y; Kawaji T; Kurimoto Y; Nakamura T; Kuriyama N; Shibata J; Komura H; Morita K; Nishida O
Blood Purif; 2020; 49(3):295-301. PubMed ID: 31995801
[TBL] [Abstract][Full Text] [Related]
31. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.
Langenecker SA; Felfernig M; Werba A; Mueller CM; Chiari A; Zimpfer M
Crit Care Med; 1994 Nov; 22(11):1774-81. PubMed ID: 7956281
[TBL] [Abstract][Full Text] [Related]
32. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding.
Betjes MG; van Oosterom D; van Agteren M; van de Wetering J
J Nephrol; 2007; 20(5):602-8. PubMed ID: 17918147
[TBL] [Abstract][Full Text] [Related]
33. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
[TBL] [Abstract][Full Text] [Related]
34. Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study.
Joannidis M; Kountchev J; Rauchenzauner M; Schusterschitz N; Ulmer H; Mayr A; Bellmann R
Intensive Care Med; 2007 Sep; 33(9):1571-9. PubMed ID: 17563874
[TBL] [Abstract][Full Text] [Related]
35. Possible strategies to prolong circuit life during hemofiltration: three controlled studies.
Baldwin I; Tan HK; Bridge N; Bellomo R
Ren Fail; 2002 Nov; 24(6):839-48. PubMed ID: 12472205
[TBL] [Abstract][Full Text] [Related]
36. Regional anticoagulation and antiaggregation for CVVH in critically ill patients: a prospective, randomized, controlled pilot study.
Fabbri LP; Nucera M; Al Malyan M; Becchi C
Acta Anaesthesiol Scand; 2010 Jan; 54(1):92-7. PubMed ID: 19650808
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulation options for patients with heparin-induced thrombocytopenia requiring renal support in the intensive care unit.
Davenport A
Contrib Nephrol; 2007; 156():259-66. PubMed ID: 17464135
[TBL] [Abstract][Full Text] [Related]
38. The 28-day survival rates of two cytokine-adsorbing hemofilters for continuous renal replacement therapy: a single-center retrospective comparative study.
Kobashi S; Maruhashi T; Nakamura T; Hatabayashi E; Kon A
Acute Med Surg; 2019 Jan; 6(1):60-67. PubMed ID: 30651999
[TBL] [Abstract][Full Text] [Related]
39. Renal replacement therapy and anticoagulation.
Brandenburger T; Dimski T; Slowinski T; Kindgen-Milles D
Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):387-401. PubMed ID: 29248145
[TBL] [Abstract][Full Text] [Related]
40. Platelet loss across the hemofilter during continuous hemofiltration.
Mulder J; Tan HK; Bellomo R; Silvester W
Int J Artif Organs; 2003 Oct; 26(10):906-12. PubMed ID: 14636006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
